ABVC BioPharma, Inc. (ABVC)
US Market

ABVC BioPharma, Inc. (ABVC) Financial Statements


ABVC BioPharma, Inc. Financial Overview

ABVC BioPharma, Inc.'s market cap is currently ―. The company's EPS TTM is $-2.297; its P/E ratio is -0.35; ABVC BioPharma, Inc. is scheduled to report earnings on November 11, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 15.88K$ 6.11K$ 128.27K$ 588.99K$ 42.27K
Gross Profit$ -13.73K$ -66.87K$ 68.04K$ 323.58K$ 31.53K
EBIT$ -2.15M$ -2.12M$ -1.89M$ -3.55M$ -3.65M
EBITDA$ -2.14M$ -2.11M$ -1.89M$ -3.55M$ -3.64M
Net Income Common Stockholders$ -3.32M$ -2.26M$ 2.10M$ -4.86M$ -3.70M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 568.59K$ 818.98K$ 1.87M$ 1.47M$ 1.40M
Total Assets$ 16.59M$ 9.32M$ 10.73M$ 9.86M$ 10.48M
Total Debt$ 3.41M$ 5.18M$ 5.21M$ 3.05M$ 3.11M
Net Debt$ 2.84M$ 4.36M$ 3.34M$ 1.59M$ 1.71M
Total Liabilities$ 7.53M$ 9.69M$ 9.00M$ 6.62M$ 4.79M
Stockholders Equity$ 9.10M$ -379.31K$ 1.67M$ 3.10M$ 5.92M
Cash Flow-
Free Cash Flow$ -1.38M$ -1.34M$ -1.50M$ -461.16K$ -518.06K
Operating Cash Flow$ -1.36M$ -899.83K$ -1.50M$ -461.07K$ -513.70K
Investing Cash Flow$ -73.78K$ -440.57K-$ -83.29K$ -1.52M
Financing Cash Flow$ 1.66M$ -31.59K$ 2.21M$ -253.50K$ 603.50K
Currency in USD

ABVC BioPharma, Inc. Earnings and Revenue History

ABVC BioPharma, Inc. Debt to Assets

ABVC BioPharma, Inc. Cash Flow

ABVC BioPharma, Inc. Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis